Health ❯Healthcare ❯Regulatory Agencies
Pharmaceuticals Regulatory Bodies Drug Safety Investments Patient Advocacy Drug Development Neurology Clinical Trials Pharmaceuticals Regulatory Agencies
The European Medicines Agency cites risks of brain swelling and bleeding, prompting Eli Lilly to seek re-examination of the decision.